COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03051490
Recruitment Status : Unknown
Verified January 2018 by Anthera Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : February 13, 2017
Last Update Posted : March 8, 2018
Information provided by (Responsible Party):
Anthera Pharmaceuticals

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : February 28, 2018
Estimated Study Completion Date : June 2018
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 April 24, 2018
May 25, 2018
2 July 17, 2018
August 13, 2018